Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age.
Kitchin N, Southern J, Morris R, Hemme F, Cartwright K, Watson M, Miller E. Kitchin N, et al. Vaccine. 2006 May 1;24(18):3964-70. doi: 10.1016/j.vaccine.2006.02.018. Epub 2006 Feb 21. Vaccine. 2006. PMID: 16517034 Clinical Trial.
Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age.
Kitchin NR, Southern J, Morris R, Hemme F, Thomas S, Watson MW, Cartwright K, Miller E. Kitchin NR, et al. Arch Dis Child. 2007 Jan;92(1):11-6. doi: 10.1136/adc.2005.076109. Epub 2006 May 2. Arch Dis Child. 2007. PMID: 16670121 Free PMC article. Clinical Trial.
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Kitchin N, Southern J, Morris R, Borrow R, Fiquet A, Boisnard F, Thomas S, Miller E. Kitchin N, et al. Vaccine. 2009 Aug 13;27(37):5096-102. doi: 10.1016/j.vaccine.2009.06.049. Epub 2009 Jun 30. Vaccine. 2009. PMID: 19573637 Clinical Trial.
Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.
John T, Voysey M, Yu LM, McCarthy N, Baudin M, Richard P, Fiquet A, Kitchin N, Pollard AJ. John T, et al. Among authors: kitchin n. Vaccine. 2015 Aug 26;33(36):4579-85. doi: 10.1016/j.vaccine.2015.06.105. Epub 2015 Jul 10. Vaccine. 2015. PMID: 26165918 Free article. Clinical Trial.
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.
Sheldon E, Kitchin N, Peng Y, Eiden J, Gruber W, Johnson E, Jansen KU, Pride MW, Pedneault L. Sheldon E, et al. Among authors: kitchin n. Vaccine. 2016 Apr 19;34(18):2082-91. doi: 10.1016/j.vaccine.2016.03.010. Epub 2016 Mar 15. Vaccine. 2016. PMID: 26993331 Clinical Trial.
Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.
Collins CL, Salt P, McCarthy N, Chantler T, Lane L, Hemme F, Diggle L, Buttery J, Kitchin NR, Moxon ER, Pollard AJ. Collins CL, et al. Among authors: kitchin nr. Vaccine. 2004 Oct 22;22(31-32):4262-9. doi: 10.1016/j.vaccine.2004.04.027. Vaccine. 2004. PMID: 15474717 Clinical Trial.
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
Lawrence J, Kitchin N, Anderson AS, Pride MW, Jansen KU, Gruber WC, Peng Y, Yi K, Knirsch C, Webber C. Lawrence J, et al. Among authors: kitchin n. Vaccine. 2021 Sep 24;39(40):5991-6003. doi: 10.1016/j.vaccine.2021.05.028. Epub 2021 Sep 3. Vaccine. 2021. PMID: 34483022 Clinical Trial.
49 results